- Report
- January 2024
- 222 Pages
Global
€4767EUR$4,995USD£3,994GBP
- Report
- March 2020
- 236 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- November 2023
- 85 Pages
Global
From €2815EUR$2,950USD£2,359GBP
- Report
- November 2023
- 74 Pages
Africa, Middle East
From €2815EUR$2,950USD£2,359GBP
- Report
- November 2023
- 74 Pages
From €2815EUR$2,950USD£2,359GBP
- Report
- November 2023
- 88 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- November 2023
- 91 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Report
- November 2023
- 82 Pages
North America
From €2815EUR$2,950USD£2,359GBP
- Report
- November 2023
- 165 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- October 2023
- 77 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2022
- 300 Pages
Global
From €3522EUR$3,690USD£2,951GBP
The Mucus Clearance Device (MCD) market is a subset of the larger Respiratory Devices market. MCDs are used to help clear mucus from the airways of patients with respiratory conditions such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and bronchiectasis. These devices typically use a combination of airway pressure, vibration, and suction to help loosen and remove mucus from the airways.
MCDs are used in both home and hospital settings, and are available in a variety of forms, including hand-held devices, masks, and chest-mounted systems. They are typically used in conjunction with other respiratory therapies, such as chest physiotherapy and aerosolized medications.
The MCD market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include Philips Respironics, Hill-Rom, ResMed, Fisher & Paykel Healthcare, and Vyaire Medical. Show Less Read more